1. Home
  2. GROW vs BOLD Comparison

GROW vs BOLD Comparison

Compare GROW & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • BOLD
  • Stock Information
  • Founded
  • GROW 1968
  • BOLD 2018
  • Country
  • GROW United States
  • BOLD United States
  • Employees
  • GROW N/A
  • BOLD N/A
  • Industry
  • GROW Investment Managers
  • BOLD
  • Sector
  • GROW Finance
  • BOLD
  • Exchange
  • GROW Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • GROW 31.8M
  • BOLD 24.4M
  • IPO Year
  • GROW N/A
  • BOLD 2024
  • Fundamental
  • Price
  • GROW $2.37
  • BOLD $1.19
  • Analyst Decision
  • GROW
  • BOLD Buy
  • Analyst Count
  • GROW 0
  • BOLD 3
  • Target Price
  • GROW N/A
  • BOLD $4.00
  • AVG Volume (30 Days)
  • GROW 29.6K
  • BOLD 105.1K
  • Earning Date
  • GROW 09-09-2025
  • BOLD 08-11-2025
  • Dividend Yield
  • GROW 3.69%
  • BOLD N/A
  • EPS Growth
  • GROW N/A
  • BOLD N/A
  • EPS
  • GROW 0.01
  • BOLD N/A
  • Revenue
  • GROW $8,932,000.00
  • BOLD N/A
  • Revenue This Year
  • GROW N/A
  • BOLD N/A
  • Revenue Next Year
  • GROW N/A
  • BOLD N/A
  • P/E Ratio
  • GROW $232.40
  • BOLD N/A
  • Revenue Growth
  • GROW N/A
  • BOLD N/A
  • 52 Week Low
  • GROW $2.02
  • BOLD $1.00
  • 52 Week High
  • GROW $2.69
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • GROW 41.60
  • BOLD N/A
  • Support Level
  • GROW $2.43
  • BOLD N/A
  • Resistance Level
  • GROW $2.58
  • BOLD N/A
  • Average True Range (ATR)
  • GROW 0.07
  • BOLD 0.00
  • MACD
  • GROW -0.01
  • BOLD 0.00
  • Stochastic Oscillator
  • GROW 8.70
  • BOLD 0.00

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: